Utama › Sarkoma Tisu Lembut › Wilayah Columbia
Kajian klinikal Sarkoma Tisu Lembut di Wilayah Columbia
7 kajian untuk Sarkoma Tisu Lembut sedang mencari peserta di lokasi di Wilayah Columbia.
Bandar di Wilayah Columbia
Teks kajian rasmi (Bahasa Inggeris)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Sibley Memorial Hospital, Washington D.C.
Mengambil peserta
Sehingga umur 39 · Semua jantina · Dikemas kini 13 Jul 2026 · NCT06796543Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
Mengambil pesertaFasa 1/2
12 Months – 30 Years · Semua jantina · Dikemas kini 19 Mei 2026 · NCT04901702Pre-operative Hypofractionated Proton Therapy
- Sibley Memorial Hospital, Washington D.C.
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Apr 2026 · NCT05917301Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's National Hospital, Washington D.C.
Mengambil pesertaFasa 1/2
Umur 2 hingga 30 · Semua jantina · Dikemas kini 3 Feb 2026 · NCT05734066Pediatric Radiation Therapy Registry
- Sibley Memorial Hospital, Washington D.C.
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 26 · Semua jantina · Dikemas kini 5 Nov 2025 · NCT07129317A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
Mengambil pesertaFasa 2
18 Months – 40 Years · Semua jantina · Dikemas kini 12 Ogo 2025 · NCT05135975Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.